Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher A. Kroeger currently holds 93,955 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher A. Kroeger has been a net neutral trader of MPLT stock. They have purchased $0 and sold $0 worth of shares.
Christopher A. Kroeger's most recent insider trade was on Aug 17, 2026, when they sold 93,955 shares at $0.00 per share.
Christopher A. Kroeger serves as Executive at MapLight Therapeutics, Inc. (MPLT). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Christopher A. Kroeger holds the position of Executive at MapLight Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Christopher A. Kroeger has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Christopher A. Kroeger was on Aug 17, 2026, when they purchased $0 worth of MPLT shares. This transaction involved 93,955 shares at N/A per share.
Christopher A. Kroeger currently owns 93,955 shares of MapLight Therapeutics, Inc. (MPLT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher A. Kroeger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher A. Kroeger has 6 Form 4 filings on record as an insider at MapLight Therapeutics, Inc..
Set alerts for Christopher A. Kroeger and 40,000+ other insiders.